• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Sunday, November 22, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Existing Exome Data Yields No Extra Diagnoses in Suspected Monogenic Diabetes

by
November 20, 2026
in Health
Reading Time: 3 mins read
0
Existing Exome Data Yields No Extra Diagnoses in Suspected Monogenic Diabetes

Existing Exome Data Yields No Extra Diagnoses in Suspected Monogenic Diabetes

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

A clinical study evaluating genetic testing strategies in patients suspected of having monogenic diabetes found that conducting research analysis on existing exome sequencing datasets yielded a diagnostic rate comparable to clinical exome-based gene panels, without identifying additional confirmed diagnostic variants. Monogenic diabetes represents an estimated 1 to 4 percent of all diabetes cases diagnosed in children and adolescents, yet the diagnostic rate among affected individuals remains notably low. Identifying specific underlying molecular causes is critical to establishing appropriate patient treatment regimens and delivering accurate genetic counseling.

To investigate diagnostic performance, researchers examined the yield of five multigene panels among 83 endocrine patients who had previously undergone clinical exome-based gene panel testing. The study cohort comprised suspected monogenic diabetes cases, of which 81 percent were pediatric patients and 55 percent were female. Alongside the evaluation of ordered clinical gene panels, investigators conducted secondary research analysis on the previously generated exome sequencing data to assess whether broader reanalysis could increase overall diagnostic yield or reveal biologically suspicious variants in genes not yet formally associated with monogenic diabetes.

During the research exome reanalysis, identified variants of interest were systematically categorized into three defined groups based on clinical and biological relevance. The first category comprised candidate diagnostic findings, defined as variants associated with the clinical indication for testing but located in genes omitted from the ordered clinical panel. The second group encompassed variants situated in candidate diabetes disease genes. The third category included incidental findings considered clinically actionable for the patient, with all relevant clinical background collected directly from electronic health records.

The initial clinical exome-based gene panel testing yielded definitive diagnostic results in a small subset of the cohort. Seven of the 83 patients, representing 8 percent of the group, received positive test results confirming a molecular diagnosis. Inconclusive findings attributable to variants of uncertain significance were documented in 37 patients, accounting for 45 percent of the cohort, while 39 patients, or 47 percent, received negative test results across the ordered multigene panels.

Among the seven individuals with positive initial panel results, pathogenic variants in the WFS1 and GCK genes represented the most frequently observed diagnostic findings, with each gene accounting for pathogenic variants in two of the seven diagnosed patients.

Subsequent research-level analysis across the previously generated exome sequencing data identified a total of 12 variants of interest distributed across 10 patients. Within this subset, researchers detected a pathogenic variant in the IGF1R gene in one patient. Because IGF1R was not included on the clinically ordered panel, the alteration was classified as a candidate diagnostic finding in light of the patient’s documented short stature.

A separate patient in the cohort harbored compound heterozygous pathogenic variants in the ARSA gene, which the investigators designated as a clinically actionable incidental finding at the time of detection. In addition, the research reanalysis uncovered nine distinct variants situated in genes that are not currently associated with diabetes diagnoses, including CAPN10 and SLC2A4, providing non-diagnostic candidate targets for subsequent investigation.

The evidence supporting the involvement of these candidate genes in diabetes-related biological pathways derived from animal models, computational predictions, pathway enrichment analyses, gene network modeling, and functional annotation predictions. Investigators concluded that while research reanalysis of existing exome sequencing data did not increase diagnostic yield beyond standard exome-based panel testing in this cohort, it offered the distinct advantage of highlighting candidate disease genes that may inform future gene discovery.

Subject of Research: Exome-based gene panel testing and secondary research exome reanalysis in suspected monogenic diabetes

Article Title: Utility of exome-based gene panel testing and research analysis of existing exome sequencing data in suspected monogenic diabetes

Article References: Vernet Machado Bressan Wilke, M., Thompson, M. L., Jho, S., Polonis, K., Rahi, H., Dickson, A., Corliss, M. M., Cao, Y., Walker, J., Sprenger, G. A., Krysiak, K., Schroeder, M. C., Stone, S., Urano, F., Neidich, J. A., & Bowling, K. M. (2026). Utility of exome-based gene panel testing and research analysis of existing exome sequencing data in suspected monogenic diabetes. Orphanet Journal of Rare Diseases. https://doi.org/10.1186/s13023-026-04675-x

Image Credits: AI Generated

DOI: 10.1186/s13023-026-04675-x

Keywords: monogenic diabetes, exome sequencing, gene panel testing, diagnostic yield, pediatric endocrinology, GCK, WFS1, IGF1R, ARSA, CAPN10, SLC2A4, variants of uncertain significance, incidental findings, candidate disease genes, clinical genetics

News Source: Juliet Wilcox. (November 20, 2026). Existing Exome Data Yields No Extra Diagnoses in Suspected Monogenic Diabetes. Scienmag.

Tags: ARSAcandidate disease genesCAPN10clinical geneticsdiagnostic yieldexome sequencingGCKGene panel testingIGF1Rincidental findingsmonogenic diabetesPediatric EndocrinologySLC2A4Variants of uncertain significanceWFS1
Share12Tweet7Share2ShareShareShare1

Related Posts

Cementless Megaprosthesis Achieves Favorable Long-Term Stability After Bone Tumor Resection

Cementless Megaprosthesis Achieves Favorable Long-Term Stability After Bone Tumor Resection

November 22, 2026
Review Assesses Skin Reactions Across Modern Diabetes and Obesity Therapies

Review Assesses Skin Reactions Across Modern Diabetes and Obesity Therapies

November 22, 2026

Hemodialysis Frailty Profiles Show No Significant Link to Hospitalization After Adjustment

November 22, 2026

Rare Neural Autoantibodies Identified in Cerebrospinal Fluid in Schizophrenia Spectrum Disorders

November 22, 2026

POPULAR NEWS

  • Cementless Megaprosthesis Achieves Favorable Long-Term Stability After Bone Tumor Resection

    Cementless Megaprosthesis Achieves Favorable Long-Term Stability After Bone Tumor Resection

    29 shares
    Share 12 Tweet 7
  • Review Assesses Skin Reactions Across Modern Diabetes and Obesity Therapies

    29 shares
    Share 12 Tweet 7
  • LLM-Enhanced BERTopic Improves Topic Coherence and Diversity in Specialized Tourism Corpus

    29 shares
    Share 12 Tweet 7
  • Hemodialysis Frailty Profiles Show No Significant Link to Hospitalization After Adjustment

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Cementless Megaprosthesis Achieves Favorable Long-Term Stability After Bone Tumor Resection

Review Assesses Skin Reactions Across Modern Diabetes and Obesity Therapies

LLM-Enhanced BERTopic Improves Topic Coherence and Diversity in Specialized Tourism Corpus

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 89 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.